336 related articles for article (PubMed ID: 34057709)
21. Site-specific estrogen and progestin regulation of orphanin FQ/nociceptin and nociceptin opioid receptor mRNA expression in the female rat limbic hypothalamic system.
Sinchak K; Romeo HE; Micevych PE
J Comp Neurol; 2006 May; 496(2):252-68. PubMed ID: 16538678
[TBL] [Abstract][Full Text] [Related]
22. Structure-Based SAR in the Design of Selective or Bifunctional Nociceptin (NOP) Receptor Agonists.
Meyer ME; Doshi A; Yasuda D; Zaveri NT
AAPS J; 2021 May; 23(3):68. PubMed ID: 33974173
[TBL] [Abstract][Full Text] [Related]
23. Discovery of small-molecule nonpeptide antagonists of nociceptin/orphanin FQ receptor: The studies of design, synthesis, and structure-activity relationships for (4-arylpiperidine substituted-methyl)-[bicyclic (hetero)cycloalkanobenzene] derivatives.
Hayashi S; Ohashi K; Mihara S; Nakata E; Emoto C; Ohta A
Eur J Med Chem; 2016 May; 114():345-64. PubMed ID: 27043173
[TBL] [Abstract][Full Text] [Related]
24. Nociceptin Receptors Upregulated in Cocaine Use Disorder: A Positron Emission Tomography Imaging Study Using [
Narendran R; Tollefson S; Himes ML; Paris J; Lopresti B; Ciccocioppo R; Mason NS
Am J Psychiatry; 2019 Jun; 176(6):468-476. PubMed ID: 31055968
[TBL] [Abstract][Full Text] [Related]
25. Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.
Gavioli EC; Calo' G
Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):319-30. PubMed ID: 16491387
[TBL] [Abstract][Full Text] [Related]
26. Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation.
Rekik K; Faria Da Silva R; Colom M; Pacifico S; Zaveri NT; Calo' G; Rampon C; Frances B; Mouledous L
Neuropharmacology; 2017 Oct; 125():39-49. PubMed ID: 28705439
[TBL] [Abstract][Full Text] [Related]
27. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
Zaveri NT
Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
[TBL] [Abstract][Full Text] [Related]
28. 1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices.
Liao YY; Trapella C; Chiou LC
Eur J Pharmacol; 2009 Mar; 606(1-3):84-9. PubMed ID: 19374842
[TBL] [Abstract][Full Text] [Related]
29. Nociceptin/orphanin-FQ modulation of learning and memory.
Abdel-Mouttalib O
Vitam Horm; 2015; 97():323-45. PubMed ID: 25677778
[TBL] [Abstract][Full Text] [Related]
30. [Nociceptin/orphanin FQ (N/OFQ)--the opioid, antiopioid or neuromodulator?].
Kotlińska J; Rafalski P
Postepy Hig Med Dosw (Online); 2004 Apr; 58():209-15. PubMed ID: 15114256
[TBL] [Abstract][Full Text] [Related]
31. Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test.
Silva EF; Silva AI; Asth L; Souza LS; Zaveri NT; Guerrini R; Calo' G; Ruzza C; Gavioli EC
Behav Brain Res; 2019 Jan; 356():120-126. PubMed ID: 30142397
[TBL] [Abstract][Full Text] [Related]
32. Nociceptin system as a target in sepsis?
Thomas R; Stover C; Lambert DG; Thompson JP
J Anesth; 2014 Oct; 28(5):759-67. PubMed ID: 24728719
[TBL] [Abstract][Full Text] [Related]
33. Cloning and characterization of the rhesus monkey nociceptin/orphanin FQ receptor.
Koga K; Ichikawa D; Nambu H; Azuma-Kanoh T; Sakai N; Takaki-Kawagoe H; Ozaki S; Ohta H
Genes Genet Syst; 2009 Oct; 84(5):319-25. PubMed ID: 20154418
[TBL] [Abstract][Full Text] [Related]
34. NOP-Related Mechanisms in Pain and Analgesia.
Toll L; Ozawa A; Cippitelli A
Handb Exp Pharmacol; 2019; 254():165-186. PubMed ID: 31119465
[TBL] [Abstract][Full Text] [Related]
35. The effects of nociceptin peptide (N/OFQ)-receptor (NOP) system activation in the airways.
Singh SR; Sullo N; D'Agostino B; Brightling CE; Lambert DG
Peptides; 2013 Jan; 39():36-46. PubMed ID: 23123316
[TBL] [Abstract][Full Text] [Related]
36. Nociceptin/orphanin FQ and NOP receptor gene regulation after acute or repeated social defeat stress.
Green MK; Devine DP
Neuropeptides; 2009 Dec; 43(6):507-14. PubMed ID: 19720395
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the NOP receptor signaling affects resilience to acute stress.
Holanda VAD; Pacifico S; Azevedo Neto J; Finetti L; Lobão-Soares B; Calo G; Gavioli EC; Ruzza C
J Psychopharmacol; 2019 Dec; 33(12):1540-1549. PubMed ID: 31337258
[TBL] [Abstract][Full Text] [Related]
38. The endogenous nociceptin/orphanin FQ-NOP receptor system as a potential therapeutic target for intestinal disorders.
Agostini S; Petrella C
Neurogastroenterol Motil; 2014 Nov; 26(11):1519-26. PubMed ID: 25307525
[TBL] [Abstract][Full Text] [Related]
39. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.
Guerrini R; Carra' G; Calo' G; Trapella C; Marzola E; Rizzi D; Regoli D; Salvadori S
J Pept Res; 2004 Jun; 63(6):477-84. PubMed ID: 15175020
[TBL] [Abstract][Full Text] [Related]
40. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices.
Chiou LC; Chuang KC; Wichmann J; Adam G
J Pharmacol Exp Ther; 2004 Nov; 311(2):645-51. PubMed ID: 15254141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
